How Women are Leading Medical Innovation

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA

From 1990 to 2016, the share of women in the life sciences industry increased from 34 to 47 percent. Women also make up more than half of Ph.Ds. in biological and agricultural sciences. And many researchers are working to address health issues affecting women, ranging from endometriosis to heart conditions. Industry leaders, policymakers and academics have also shown how they’re dedicated to continuing to support innovation — and this includes fostering the next generation of scientists through STEM education programs.

The panelists will discuss what the new era of medicine means for women’s health, how the biopharmaceutical industry is empowering women and girls, and what they think the future of science will look like.

To RSVP for this event, please visit here .

Speakers

Lori Reilly, executive vice president, policy, research and membership, PhRMA
Dr. Anne Pritchett, senior vice president, policy, research and membership, PhRMA
Charlotte Jones-Burton, M.D., M.S. , executive director, R&D, innovative medicines development, development team lead, cardiovascular, Bristol Myers Squibb
Dr. Sabine Luik , chief medical officer and senior vice president, Global Medical, Regulatory and Quality, GSK
Amy M. Miller, Ph.D., president and CEO, the Society for Women’s Health Research
Jean Beebe, Ph.D., vice president, clinical portfolio leader, inflammation and immunology, Pfizer
Lana Skirboll, Ph.D., vice president of science policy, Sanofi

Other speakers to be announced.

When

Wednesday, May 1, 2019
10:00 AM - 11:00 AM EST

Where

Cannon House Office Building
Room 122
Independence Ave SE
Washington, DC 20003

Event

Science